Lung Transplant Candidates: Shining a Light on UCSF’s Evaluation ProcessIn this short presentation, pulmonologist Jeffrey A. Golden, MD, describes how the specialists of the UCSF Lung Transplant Program work together to ensure their patients are likely to succeed, with a focus on factors that can make or break survival prospects.
Living Donor Renal TransplantIn this narrated surgical video, Chris Friese, MD, performs a right laparoscopic donor nephrectomy.
Lung Cancer Screening: Who, How and When to Refer†horacic radiologist Brett M. Elicker, MD, and thoracic surgeon Johannes Kratz, MD, present about current lung cancer screening guidelines: who, how, and when to refer.
How Technology, Human Values and New Scrutiny of Old Methods Are Improving Cancer OutcomesThree surgical oncologists offer exciting news on hepatobiliary, thyroid and breast cancers. First up is a look at benefits of minimally invasive robotic surgery for rectal cancers; regional therapy for metastatic GI cancer; 3D virtual surgical planning; and biomarkers for pancreatic cysts.
Know Your Thyroid: Here’s Help With Understanding Nodules and CancerThyroid disease is increasingly common. In this video, UCSF specialists clearly explain the basics of thyroid nodules and thyroid cancer, helping patients make sense of their treatment options, from monitoring to surgery to radioactive iodine.
Update on Liver Lesions: What Works in Managing HCCBased on clear metrics, transplant hepatologist Neil Mehta, MD, presents diagnostic criteria for hepatocellular carcinoma, then shows how UCSF’s HCC team reaches decisions on treatment for individual cases – with plans ranging from resection or ablation to downstaging drugs and transplantation.
Adrenal Tumors and Posterior Retroperitoneoscopic Adrenalectomy (PRA): A Case StudySanziana Roman, MD, an endocrine surgeon, discusses a patient’s treatment for a tumor in the retroperitoneum, near the adrenal gland.
Personalized Therapy for Early-Stage Lung Cancer at UCSFFollow the journey of a UCSF patient with early-stage, high-risk lung cancer, from history to treatment and prognosis, including how surgeons chose to do a robotic assisted VATS lobectomy and an analysis of how well chemo is likely to work for her.